The short answer
Panax ginseng’s glucose effects vary, and an increased hypoglycemia risk with insulin isophane has not been established. Species and extract differences are important.
What this answer covers
Asian Panax ginseng, including specific root-extract studies; American ginseng is a separate species.
- Supplement or preparation
- Panax ginseng
- Medication ingredient
- insulin isophane
Some findings were null or opposite
Two acute studies of Asian ginseng found no overall improvement in glucose or insulin responses, with a higher two-hour glucose measure in pooled treatment. Results cannot simply be borrowed from American ginseng.
A particular extract showed benefit
A short vinegar-extracted-ginseng study reported improved HbA1c in drug-naive diabetes patients. It did not test insulin isophane, so it cannot measure combination hypoglycemia.
One product cannot represent all ginseng
Processing and constituent content change the exposure. The contrasting studies do not establish a safe glulisine combination dose or show that every ginseng product lowers glucose.
Monitoring does not establish a spacing rule
Discuss the exact product and amount with the diabetes team before starting or stopping it. Follow your glucose-monitoring and low-glucose treatment plan. Do not adjust insulin yourself. Neither clinical study tests an hour-based gap or establishes universal avoidance with NPH.
Evidence and practical considerations
Side effects & toxicity
Indirect preparation-specific glucose evidence does not establish added clinical hypoglycemia with insulin isophane.
- Exact scope
- Asian Panax ginseng, including specific root-extract studies; American ginseng is a separate species. with Insulin isophane RxCUI1605101 IN; human NPH subcutaneous suspension label bridge.
- Medication form and route
- subcutaneous insulin isophane; oral supplement
What remains uncertain
- No exact event rate or arbitrary dose adjustment.
Factors that may matter: Product; Dose; Meals; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Two groups of11healthy volunteers.
No significant overall glucose/insulin effect; pooled Asian-ginseng treatment had higher two-hour glucose than placebo.
How this applies: Indirect for exact insulin isophane; study drug, supplement form and outcome retained.
Small healthy-volunteer studies; not glipizide co-use. Contradicts automatic transfer of American-ginseng results to Panax ginseng. This does not establish an exact insulin-isophane interaction.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 72drug-naive adults with type 2 diabetes.
Vinegar-extracted Panax ginseng improved HbA1c in a small trial, with no severe adverse events reported in the abstract.
How this applies: Indirect for exact insulin isophane; study drug, supplement form and outcome retained.
Drug-naive patients; not glipizide. Specialized extract not interchangeable with all root products. This does not establish an exact insulin-isophane interaction.
Research assessment: · Open full citations ↗
Timing & monitoring
No established spacing interval or universal avoidance rule for this exact preparation with NPH; glucose review remains appropriate.
- Exact scope
- Asian Panax ginseng, including specific root-extract studies; American ginseng is a separate species. with Insulin isophane RxCUI1605101 IN; human NPH subcutaneous suspension label bridge.
- Medication form and route
- subcutaneous insulin isophane; oral supplement
What remains uncertain
- No exact event rate or arbitrary dose adjustment.
Factors that may matter: Product; Dose; Meals; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Two groups of11healthy volunteers.
No significant overall glucose/insulin effect; pooled Asian-ginseng treatment had higher two-hour glucose than placebo.
How this applies: Indirect for exact insulin isophane; study drug, supplement form and outcome retained.
Small healthy-volunteer studies; not glipizide co-use. Contradicts automatic transfer of American-ginseng results to Panax ginseng. This does not establish an exact insulin-isophane interaction.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 72drug-naive adults with type 2 diabetes.
Vinegar-extracted Panax ginseng improved HbA1c in a small trial, with no severe adverse events reported in the abstract.
How this applies: Indirect for exact insulin isophane; study drug, supplement form and outcome retained.
Drug-naive patients; not glipizide. Specialized extract not interchangeable with all root products. This does not establish an exact insulin-isophane interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact isophane article with human NPH product bridge and source-specific clinical limits. | |
| Research summary published |
Article revision: 525fe14323e59885
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.